delayed. The one false positive report was accounted for by a very proliferative smear from a fibroadenoma, an error probably due to lack of cytological experience. Zajicek has shown that with experience, false positive reports can be largely eliminated.
If we consider the 85 lesions assessed clinically and thought to be malignant the accuracy of cytology was less satisfactory. Only 5 lesions were correctly diagnosed as benign, while the false negative reports were undoubtedly due to errors of samplingall were scirrhous carcinomas. Nevertheless, while stressing that a clinical diagnosis of malignancy must always override a cytological opinion we can, by adopting a combined clinical and cytological approach, provide a firmer basis for the diagnosis of benign breast disease.
It is, however, in assessing the doubtful cases that we hope' cytology can make the most valuable contribution. Indeed, in 17 of the lesions reported as malignant, we were correct in all but one, which was found later to be a cylindroma. We reported 23 of the cases correctly as benign, but the 5 erroneous false negative reports were again sampling errors. Of the women with clinically doubtful lesions, 19 had mammograms, and in 14 patients the cytological and mammographic findings were concordant and consistent with the final diagnosis. These results suggest that our combined cytologic and mammographic investigations of doubtful lumps could provide a reliable assessment of the lesion, when the results are in agreement. This aspect of the application of cytology should be investigated further, for where both tests are carried out, their concordance could provide a diagnosis with a very high degree of accuracy.
In summary then, this safe, convenient and accurate test would seem to warrant more general use, especially to confirm lesions diagnosed clinically and radiologically as benign, while its role in the diagnosis of lesions of doubtful malignancy needs to be explored further.
It has been found that this test can be of value to the surgeon in his initial assessment of the patient prior to surgery and, if considered together with clinical and radiological findings, of considerable assistance in the selection of cases for frozen section or excision biopsy. The examination of urine for malignant cells in asymptomatic individuals is only a worthwhile procedure in a selected group known to be at risk. Several reports have demonstrated the futility of screening the general population for bladder cancer. The largest group examined was 6500 patients over 40 years of age in a general hospital with symptoms other than those suggesting disease of the genitourinary tract (Macfarlane 1963). Not one case of cancer of the bladder was revealed.
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The association between bladder cancer and industry has been known for many years, since Rehn (1895) first established it in the German dye industry. The chemical responsible was thought to be aniline, but it is now known from work on experimental animals that the carcinogenic agents are ,B-naphthylamine, a-naphthylamine and benzidine, all of which were used as intermediates in the dye industry. The most potent of these is fi-naphthylamine, and in a survey of the chemical industry (Case et al. 1954) to investigate the association between the industry and bladder tumour, all 15 workers involved in distilling ,B-naphthylamine during its manufacture developed bladder cancer. Case established the expected incidence of death from bladder cancer from an examination of death certificates, and found that in workers exposed to these compounds there were 127 deaths from bladder tumours compared to an expected incidence of 4, proving beyond doubt that there was a high risk of developing bladder cancer among workers in this industry.
By the time this survey was complete the manufacture of fl-naphthylamine was banned in this country, but it became gradually apparent that there was a risk of developing bladder cancer in other industries where these carcinogenic agents had been used. Thus the rubber and cable industries, in which antioxidants containing a-and ,B-naphthylamine were used to prevent the rubber perishing, were found to be associated with a risk of developing bladder cancer. Similarly, in gas works, workers in the retort houses had an increased risk, and ,Bnaphthylamine has been identified in coal tar and gas works pitch. Textile printers where the dye was developed onto the cloth with these agents were also at risk, as well as laboratory workers who used benzidine as a test for occult blood. Sewage workers used a chemical which was found to contain a-naphthylamine for testing water supplies, and rat catchers may have been exposed to the same.substance which was present as an impurity in the rodenticide Antu.
The first report of urine examination for the detection of bladder cancer came from Germany, when Oppenheimer (1920) advocated the examination of centrifuged urine for red blood cells in workers at risk in the aniline dye industry. The same procedure was adopted in the UK in the 1930s, and many of the patients with bladder cancer reviewed in Case's survey were detected by this method.
Screening urine for red blood cells remained the method most widely used for early detection until Papanicolaou & Marshall (1945) denionstrated that bladder carcinoma cells exfoliated into the urine could be recognized and the method used as a diagnostic test. In 1956 Crabbe and his colleagues' in the UK reported the results of the examination of urine from 1800 workers at risk, using both the 'wet smear' technique for red blood cells and the 'Papanicolaou test' for abnormal epithelial cells. The superiorEty of the latter method was clearly demonstrated and the examination of a spun sample of urine with or without a millipore filter is now the laboratory method of choice.
Despite the fact that the carcinogenic agents were banned from use in the late 1940s, not all firms adhered to this rule. The induction time between exposure and development' of the disease was shown by Case to extend over 45 years so that regular surveillance of exposed individuals is still necessary, although the total number at risk must be falling. Screening schemes are run under the auspices of the Association of British Chemical Manufacturers and the Rubber Manufacturing Employers' Association. In a paper read to this Society Dr Parkes of the RMEA enumerated guidelines for the establishment of a successful urine cytology screening service (Parkes 1971) . These include the need to avoid unnecessary anxiety, especially in the elderly, the need for an efficient recall system, and the importance of -the incorporation of urologists into the scheme at an early stage so that hospital staff might be aware of the possible increase in workload. Dr Parkes' laboratory (Parkes 1976, personal communication) examines specimens at 4-6-monthly intervals from workers at risk, amounting to 500-600 specimens a week. On average 10 cases of bladder cancer are detected annually, which probably represents a true incidence rate for the disease.
In addition to these screening projects for specific industries many laboratories around the country have undertaken to examine urine from workers in local firms where there was formerly an exposure hazard. At St Stephen's Hospital this amounts to approximately 35 specimens a year from about 120 individuals. One carcinoma was detected in a rubber worker, and was eventually found arising in the ureter. This man is now well after extensive surgery and he has been financially compensated. At Kingston Hospital about 100 people at a sewage works and a rubber factory have specimens examined in Dr Powell's laboratory. One case of squamous carcinoma has been detected as well as a man with a ureteric stone who exfoliated atypical cells.
Following press publicity in 1965 the then Ministry of Health instigated a scheme for bladder cancer screening by which people thought to be at risk were notified by letter and advised to attend their general practitioner. This scheme had little success, although the publicity probably prompted many firms to seek the help of their local hospital laboratory and screening programmes became established in this way.
In July 1975, the Department of Health and Social Security organized a second scheme (Health Service Circular, (IS) 170) for urine screening involving primarily the Area Medical Officer and the NHS Central Register at Southport. With the cooperation of the Department of Employment the Register has filed the names and last known addresses of about 16 000 individuals at risk from various industries. The Register notifies the GP who in turn advises the AMO that the person's address is correct and that it is not inappropriate to collect a urine specimen, e.g. that the person is not already under medical care of some kind. The AMO then sends the person a letter and a bottle containing preservative with instructions and a label addressed to the local district hospital laboratory.
How this system will work it is too early to tell, but it is reported that even at this early stage a few cases with positive cytology have been detected, although the response rate is disappointingly low.
The DHSS has 92 laboratories registered for urine cytology, which seems a high number in view of the specialized nature of the investigation. Laboratories where few urine specimens are seen for cytodiagnosis are at a disadvantage for the correct identification of abnormalities that occur infrequently. Perhaps a smaller number of registered laboratories would increase the efficiency of the service and allow precious resources to be released.
It is clear, however, that cases of bladder cancer resulting from industrial exposure are still being revealed and there is a definite need for urine screening programmes.
